Answers are grounded in this paper and cite their sources.
Uncovers impaired oxidative metabolism in cardiac mitochondria due to tafazzin deficiency, suggesting broader metabolic implications.
mitochondria with exogenous CoA partially rescued pyruvate and palmitoylcarnitine oxidation capacities, implicating dysregulation of CoA-dependent intermediary metabolism rather than respiratory chain defects in the bioenergetic impacts of tafazzin deficiency. These findings support links among cardiolipin abnormalities, respiratory supercomplex instability, and mitochondrial oxidant production and shed new light on the distinct metabolic consequences of tafazzin deficiency in the mammalian heart.
No takes yet. Share an insight, caveat, or question.
Le et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: